Inhibrx Biosciences Eulerpool News

Inhibrx Biosciences Aktie News

Inhibrx Biosciences wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Inhibrx Biosciences News stellen wir hier zusammen.

• 18. Juli ·

  SeekingAlpha
  Inhibrx Biosciences: Seeing Soon If The Momentum Is Just Hype
• 17. Juli ·

  Yahoo
  Ligand Pharmaceuticals Stock Earns 84 RS Rating
• 14. Mai ·

  Yahoo
  Inhibrx Reports First Quarter 2025 Financial Results
• 1. April ·

  Yahoo
  Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President
• 21. Januar ·

  Yahoo
  Inhibrx Prospective Colorectal Cancer Treatment Shows Encouraging Results, Trial Expansion Planned
• 21. Januar ·

  Yahoo
  Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer
• 17. November ·

  Yahoo
  The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
• 14. November ·

  Yahoo
  Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
• 5. November ·

  SeekingAlpha
  Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique Platform
• 4. November ·

  Yahoo
  Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation